-+ 0.00%
-+ 0.00%
-+ 0.00%

Biofrontera announced that Ameluz® red light photodynamic therapy has been approved by the FDA for the treatment of superficial basal cell carcinoma.

Zhitongcaijing·09/14/2026 13:33:07
Listen to the news
Biofrontera announced that Ameluz® red light photodynamic therapy has been approved by the FDA for the treatment of superficial basal cell carcinoma.